Company profilePharmaceutical#855 of 1,318 in Pakistan✓ No DRAP alerts

LUNDBECK PAKISTAN (PVT) LTD.

Pharmaceutical company · 8 brands · 7 molecules

Ranked #19 of 62 companies in Neuro

8 registered products 8 pharmaceutical brands 7 distinct molecules 0 DRAP alerts

Company overview

8
registered products
8
pharmaceutical brands
7
distinct molecules
4
therapeutic classes
0
DRAP alerts

LUNDBECK PAKISTAN (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 8 product registrations across 7 distinct molecules. Its portfolio is concentrated in Neuro and Antidepressants. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by LUNDBECK

11 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Other Nervous System Drugs 2

Top molecules by brand count

Therapeutic classes

Neuro · 6Antidepressants · 3Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 2Other Nervous System Drugs · 1

Conditions treated

Anxiety/Depression/Insomnia · 3Schizophrenia/Psychosis · 2Alzheimer`S · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO4 products · Rs 809.14 – Rs 7,079.66
Servaid10 products · Rs 538.62 – Rs 12,118.96
Median across source: Rs 3,141.27

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

NABIQASIM INDUSTRIES (PVT) LTD. holds 192 molecules not in this portfolio
2 MiuAcefyllin PiperazineAcefyllineAcetaminophinAcetylsalicyclic AcidAcyclovir
PharmEvo Private Limited holds 117 molecules not in this portfolio
AgomelatineAlcoholAmlodipineAnastrazoleApixabanAprepitant
Horizon Pharmaceuticals (Pvt) Limited holds 136 molecules not in this portfolio
000 I.UAcyclovirAlbendazoleAmlodipineAmoxicillinAmoxycillin Base

Get the full profile for LUNDBECK

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.